A win-win-win scenario: Patients will be ultimate beneficiaries of the AO's Clinical Study Hub
"The beautiful part of this project is that it really demonstrates the AO’s global network of expertise. The AO has a wide global network of surgeons who are eager to participate in clinical studies, the research know-how from the AO ITC Clinical Evidence team, as well as a group of committed key opinion leaders with knowledge and passion"
Yabin Wu, AO Spine Knowledge Forum (KF) Manager
The AO's Clinical Study Hub is envisioned as a scalable approach that initially would serve the AO’s own need for high-quality, cost-effective truly global clinical studies. The platform will eventually be offered to industrial partners and orthopedic research groups who have the same need.
The aim of AO's Clinical Study Hub is a win-win-win scenario benefitting all involved. “Clinical study clients will meet their clinical study need with higher quality, in less time, and at a lower budget more effectively,” he says. “Participating surgeons and clinical centers will receive sufficient technical and financial support to more easily join international studies; the AO's Clinical Study Hub will maintain its long-term sustainability: and the AO—as the owner of the AO's CSH —will grow a large, global, collaborative clinical study network, and extend its leadership in clinical evidence and knowledge generation.”
The aim of AO's Clinical Study Hub is a win-win-win scenario benefitting all involved. “Clinical study clients will meet their clinical study need with higher quality, in less time, and at a lower budget more effectively,” he says. “Participating surgeons and clinical centers will receive sufficient technical and financial support to more easily join international studies; the AO's Clinical Study Hub will maintain its long-term sustainability: and the AO—as the owner of the AO's CSH —will grow a large, global, collaborative clinical study network, and extend its leadership in clinical evidence and knowledge generation.”